Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trichoderma viride
- Development stage
- Unknown
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Intradermal, Topical, Seed Treatment, Soil Application
01
Overview
Trichoderma viride is a filamentous fungus widely used as a biofungicide and biological control agent in agriculture. It is applied to seeds and soil to suppress plant diseases caused by pathogenic fungi such as Rhizoctonia, Pythium, Fusarium species, Macrophomina phaseolina, and others. The mechanism of action involves competitive exclusion (outcompeting pathogens for space and nutrients), secretion of antifungal compounds (including cell wall-degrading enzymes and antibiotics), direct parasitism of pathogenic fungi, induction of systemic resistance in plants (triggering plant defense responses), and promotion of plant growth. In medicine, Trichoderma viride extract is used as a non-standardized fungal allergenic extract for allergy testing; it can provoke allergic reactions by increasing histamine release and stimulating cell-mediated immunity[1][2][3][6].
- Other names
- Trichoderma virideHypocrea rufa
Beyond the preview
Go deeper on Trichoderma viride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trichoderma viride.